971 related articles for article (PubMed ID: 26362400)
21. [Viral gene transfer medicinal products. Therapy with "disarmed" human pathogens].
Winckler T
Pharm Unserer Zeit; 2011 May; 40(3):202-11. PubMed ID: 21698609
[No Abstract] [Full Text] [Related]
22. Viral gene therapy strategies: from basic science to clinical application.
Young LS; Searle PF; Onion D; Mautner V
J Pathol; 2006 Jan; 208(2):299-318. PubMed ID: 16362990
[TBL] [Abstract][Full Text] [Related]
23. Viral Vector-Based Gene Therapy.
Li X; Le Y; Zhang Z; Nian X; Liu B; Yang X
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175441
[TBL] [Abstract][Full Text] [Related]
24. Novel vectors for in vivo gene delivery to vascular tissue.
White K; Nicklin SA; Baker AH
Expert Opin Biol Ther; 2007 Jun; 7(6):809-21. PubMed ID: 17555367
[TBL] [Abstract][Full Text] [Related]
25. Virus-mediated gene delivery to neuronal progenitors.
Rex TS
Adv Exp Med Biol; 2008; 613():147-53. PubMed ID: 18188939
[No Abstract] [Full Text] [Related]
26. Genetically engineering adenoviral vectors for gene therapy.
Coughlan L
Methods Mol Biol; 2014; 1108():23-40. PubMed ID: 24243238
[TBL] [Abstract][Full Text] [Related]
27. Optimizing gene delivery vectors for the treatment of heart disease.
Gray SJ; Samulski RJ
Expert Opin Biol Ther; 2008 Jul; 8(7):911-22. PubMed ID: 18549322
[TBL] [Abstract][Full Text] [Related]
28. Lentiviral-mediated gene transfer of siRNAs for the treatment of Huntington's disease.
Cambon K; Déglon N
Methods Mol Biol; 2013; 1010():95-109. PubMed ID: 23754221
[TBL] [Abstract][Full Text] [Related]
29. Viral vectors for gene delivery and gene therapy within the endocrine system.
Stone D; David A; Bolognani F; Lowenstein PR; Castro MG
J Endocrinol; 2000 Feb; 164(2):103-18. PubMed ID: 10657846
[TBL] [Abstract][Full Text] [Related]
30. Non-integrating lentiviral vectors.
Sarkis C; Philippe S; Mallet J; Serguera C
Curr Gene Ther; 2008 Dec; 8(6):430-7. PubMed ID: 19075626
[TBL] [Abstract][Full Text] [Related]
31. [SiRNA technology, the gene therapy of the future?].
Rácz Z; Hamar P
Orv Hetil; 2008 Jan; 149(4):153-9. PubMed ID: 18201957
[TBL] [Abstract][Full Text] [Related]
32. Recent Advances in Preclinical Developments Using Adenovirus Hybrid Vectors.
Ehrke-Schulz E; Zhang W; Gao J; Ehrhardt A
Hum Gene Ther; 2017 Oct; 28(10):833-841. PubMed ID: 28854818
[TBL] [Abstract][Full Text] [Related]
33. Gene therapy.
Levine F; Friedmann T
Am J Dis Child; 1993 Nov; 147(11):1167-74. PubMed ID: 8237910
[No Abstract] [Full Text] [Related]
34. [Developments in gene delivery vectors for ocular gene therapy].
Khabou H; Dalkara D
Med Sci (Paris); 2015 May; 31(5):529-37. PubMed ID: 26059304
[TBL] [Abstract][Full Text] [Related]
35. Nonintegrating Gene Therapy Vectors.
Athanasopoulos T; Munye MM; Yáñez-Muñoz RJ
Hematol Oncol Clin North Am; 2017 Oct; 31(5):753-770. PubMed ID: 28895845
[TBL] [Abstract][Full Text] [Related]
36. Efficient Gene Suppression in Dorsal Root Ganglia and Spinal Cord Using Adeno-Associated Virus Vectors Encoding Short-Hairpin RNA.
Enomoto M; Hirai T; Kaburagi H; Yokota T
Methods Mol Biol; 2016; 1364():277-90. PubMed ID: 26472458
[TBL] [Abstract][Full Text] [Related]
37. On the Relationship of Viral Particles and Extracellular Vesicles: Implications for Viral Vector Technology.
Metzner C; Zaruba M
Viruses; 2021 Jun; 13(7):. PubMed ID: 34206771
[TBL] [Abstract][Full Text] [Related]
38. Infection control for gene therapy: a busy physician's primer.
Evans ME; Lesnaw JA
Clin Infect Dis; 2002 Sep; 35(5):597-605. PubMed ID: 12173136
[TBL] [Abstract][Full Text] [Related]
39. Vectors for gene therapy of cardiovascular disease.
Dedieu JF; Mahfoudi A; Le Roux A; Branellec D
Curr Cardiol Rep; 2000 Jan; 2(1):39-47. PubMed ID: 10980871
[TBL] [Abstract][Full Text] [Related]
40. Postexit surface engineering of retroviral/lentiviral vectors.
Metzner C; Kochan F; Dangerfield JA
Biomed Res Int; 2013; 2013():253521. PubMed ID: 23691494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
